Pfizer

September 22, 2015September 22, 2015

Pfizer Reports Favorable Results on Oral Tofacitinib for Ulcerative Colitis

News

Pfizer recently released the top-line results from two Phase III induction studies of twice-daily tofacitinib (10 mg tablets) for ulcerative colitis, within the Oral Clinical Trials for tofAcitinib in ulceratiVE colitis (OCTAVE) global ... Read more

August 21, 2014September 2, 2014

CCFA Co-Funds IBD Research in Partnership with Pfizer’s Centers for Therapeutic Innovation

IBD News, News

The Crohn’s & Colitis Foundation of America (CCFA) and Pfizer’s Centers for Therapeutic Innovation (CTI) have signed an agreement to support potential development and translational research projects for inflammatory bowel disease (IBD). ... Read more

August 15, 2014August 15, 2014

23andMe Partners With Pfizer to Research Genetics of Inflammatory Bowel Disease

IBD News, News

California-based personal genetics company 23andMe recently partnered with Pfizer to enroll 10,000 patients with Inflammatory Bowel Disease in a research initiative that will explore how genetics and environment are associated with ... Read more